Voorschoten, Netherlands

Ingrid Nicolle Michon

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ingrid Nicolle Michon: Innovator in Pharmacological Research

Introduction

Ingrid Nicolle Michon is a prominent inventor based in Voorschoten, Netherlands. She has made significant contributions to the field of pharmacology, particularly in the development of treatment regimens involving maribavir. With a total of 3 patents to her name, Michon is recognized for her innovative approaches to drug interactions and dosing strategies.

Latest Patents

Ingrid's latest patents focus on the use of maribavir in treatment regimens. One of her key patents involves the characterization of drug-drug interaction properties and pharmacological properties of maribavir. This research is crucial as it informs potential drug-drug interactions and dosing strategies when administering maribavir alongside co-medications. Her work in this area is paving the way for safer and more effective treatment options.

Career Highlights

Ingrid Michon is currently employed at Takeda Pharmaceutical Company Limited, where she continues to advance her research in pharmacology. Her expertise and dedication to her work have established her as a valuable asset in the pharmaceutical industry.

Collaborations

In her career, Michon has collaborated with notable colleagues, including Kefeng Sun and Matthew Crouthamel. These partnerships have further enhanced her research and contributed to the success of her projects.

Conclusion

Ingrid Nicolle Michon is a trailblazer in the field of pharmacological research, with a focus on maribavir and its applications in treatment regimens. Her innovative work and collaborations are making a significant impact in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…